cardiac magnetic ressonance: In patients with aortic disease submitted to endovascular repair, will be studied through cardiac magnetic ressonance to evaluate cardiac function
Study summary
To assess the effects of endovascular aortic repair on cardiac morphology and function
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
\- Patients over 18-year-old, with degenerative arch, descending thoracic or abdominal aortic aneurysms, penetrating aortic ulcers or intramural hematomas managed with total EVAR in elective setting.
Exclusion Criteria:
* Heart failure with an ejection fraction \<35 vs 50% or New York Heart Association (NYHA) class III and IV.
* LV wall motion abnormality.
* Moderate to severe valve disease.
* History of (or expected within the study period) cardiac/aortic surgery.
* Coronary artery disease.
* Atrial fibrillation.
* Congenital heart disease.
* Connective tissue disorders.
* Chronic kidney disease (eGFR \<30 mL/min/173 m2).
* Moderate to severe pulmonary disease as indicate either by post bronchodilator FEV1 (%predicted) \<50% or Modified Medical Research Council Dyspnoea Scale (mMRC) 3-4.
* CMR contraindications (non-compatible pacemakers and metal implants, and claustrophobia).
Primary outcome measure(s)
To estimate cardiac remodelling in patients who have undergone EVAR by comparing baseline left ventricular mass with those obtained after a 12-month period. — 12-month period The cardiac remodelling will be estimated through the variables of left ventricular mass at baseline and 12 months, measured in grams through CMR.
Trial sites (2)
Facility
City
Region
Status
Unidade Local de Saúde Santa Maria
Lisbon
Portugal
Recruiting
Unidade Local de Saúde de Santa Maria, E.P.E.
Lisbon
Portugal
Not Yet Recruiting
More Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa trials in Portugal
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
